Tonix Pharmaceuticals Holding Corp. (TNXP)
10.68
-0.28
(-2.55%)
USD |
NASDAQ |
Jun 11, 16:00
10.61
-0.07
(-0.66%)
After-Hours: 20:00
Tonix Pharmaceuticals Market Cap : 151.71M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 155.69M |
| June 09, 2026 | 162.79M |
| June 08, 2026 | 166.35M |
| June 05, 2026 | 157.25M |
| June 04, 2026 | 168.76M |
| June 03, 2026 | 161.94M |
| June 02, 2026 | 166.49M |
| June 01, 2026 | 174.58M |
| May 29, 2026 | 175.15M |
| May 28, 2026 | 179.56M |
| May 27, 2026 | 89.39M |
| May 26, 2026 | 93.95M |
| May 22, 2026 | 93.95M |
| May 21, 2026 | 103.00M |
| May 20, 2026 | 106.68M |
| May 19, 2026 | 100.87M |
| May 18, 2026 | 104.91M |
| May 15, 2026 | 115.80M |
| May 14, 2026 | 103.66M |
| May 13, 2026 | 101.82M |
| May 12, 2026 | 97.70M |
| May 11, 2026 | 103.81M |
| May 08, 2026 | 103.66M |
| May 07, 2026 | 100.21M |
| May 06, 2026 | 108.08M |
| Date | Value |
|---|---|
| May 05, 2026 | 99.32M |
| May 04, 2026 | 95.86M |
| May 01, 2026 | 100.06M |
| April 30, 2026 | 95.13M |
| April 29, 2026 | 91.23M |
| April 28, 2026 | 93.51M |
| April 27, 2026 | 94.47M |
| April 24, 2026 | 92.77M |
| April 23, 2026 | 91.89M |
| April 22, 2026 | 96.45M |
| April 21, 2026 | 99.40M |
| April 20, 2026 | 105.50M |
| April 17, 2026 | 102.85M |
| April 16, 2026 | 103.96M |
| April 15, 2026 | 105.50M |
| April 14, 2026 | 98.22M |
| April 13, 2026 | 95.50M |
| April 10, 2026 | 91.82M |
| April 09, 2026 | 95.64M |
| April 08, 2026 | 95.94M |
| April 07, 2026 | 96.16M |
| April 06, 2026 | 100.13M |
| April 02, 2026 | 102.27M |
| April 01, 2026 | 100.65M |
| March 31, 2026 | 101.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MetaVia, Inc. | 10.38M |
| ACADIA Pharmaceuticals, Inc. | 3.658B |
| Alnylam Pharmaceuticals, Inc. | 38.61B |
| Savara, Inc. | 1.079B |
| Vericel Corp. | 1.976B |
Market Cap Related Metrics
| PS Ratio | 6.351 |
| Price to Book Value | 0.6680 |
| Price | 10.68 |
| Earnings Yield | -134.4% |